Key Takeaways from Analyst
The global lactated ringers injection market is expected to witness steady growth over the forecast period driven by the rising prevalence of chronic diseases and increasing number of surgeries performed worldwide. Intravenous fluids such as lactated Ringers solution find wide application during surgical procedures to maintain fluid balance in patients. Moreover, the growing geriatric population who are more susceptible to chronic illnesses will further augment market growth. North America currently dominates the global lactated ringers injection market and is expected to maintain its leading position throughout the forecast period owing to well-established healthcare systems and higher healthcare spending in the region.
Asia Pacific is anticipated to emerge as the fastest growing regional market supported by rising healthcare expenditure, increasing patient population, and improving access to healthcare in developing countries of the region. However, pricing pressures from generic drug manufacturers may hinder market revenue growth to some extent. On the positive side, the production of biosimilars is expected to create new avenues for established players over the coming years. Additionally, the market is likely to benefit from increasing demand for plasma volume expanders during trauma and emergency care. Overall, with the rising disease burden globally, the lactated ringers injection market holds promising growth opportunities for manufacturers.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients